FR07C0026I2 - Procede de preparation d' un vaccin contre le papillomavirus aux particules viro-induites desassemblees et reassemblees - Google Patents

Procede de preparation d' un vaccin contre le papillomavirus aux particules viro-induites desassemblees et reassemblees

Info

Publication number
FR07C0026I2
FR07C0026I2 FR07C0026C FR07C0026C FR07C0026I2 FR 07C0026 I2 FR07C0026 I2 FR 07C0026I2 FR 07C0026 C FR07C0026 C FR 07C0026C FR 07C0026 C FR07C0026 C FR 07C0026C FR 07C0026 I2 FR07C0026 I2 FR 07C0026I2
Authority
FR
France
Prior art keywords
viro
reassembled
disassembled
preparing
vaccine against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR07C0026C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26824774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR07C0026(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR07C0026I1 publication Critical patent/FR07C0026I1/fr
Application granted granted Critical
Publication of FR07C0026I2 publication Critical patent/FR07C0026I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR07C0026C 1999-03-26 2007-03-20 Procede de preparation d' un vaccin contre le papillomavirus aux particules viro-induites desassemblees et reassemblees Active FR07C0026I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12652899P 1999-03-26 1999-03-26
US09/524,624 US6245568B1 (en) 1999-03-26 2000-03-13 Human papilloma virus vaccine with disassembled and reassembled virus-like particles
PCT/US2000/007595 WO2000057906A1 (en) 1999-03-26 2000-03-22 Human papillomavirus vaccine with disassembled and reassembled virus-like particles

Publications (2)

Publication Number Publication Date
FR07C0026I1 FR07C0026I1 (cg-RX-API-DMAC7.html) 2007-04-27
FR07C0026I2 true FR07C0026I2 (fr) 2012-08-03

Family

ID=26824774

Family Applications (1)

Application Number Title Priority Date Filing Date
FR07C0026C Active FR07C0026I2 (fr) 1999-03-26 2007-03-20 Procede de preparation d' un vaccin contre le papillomavirus aux particules viro-induites desassemblees et reassemblees

Country Status (19)

Country Link
US (2) US6245568B1 (cg-RX-API-DMAC7.html)
EP (1) EP1165126B1 (cg-RX-API-DMAC7.html)
JP (1) JP4594534B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020013516A (cg-RX-API-DMAC7.html)
AR (1) AR023166A1 (cg-RX-API-DMAC7.html)
AT (1) ATE339222T1 (cg-RX-API-DMAC7.html)
AU (1) AU778937B2 (cg-RX-API-DMAC7.html)
CA (1) CA2368391C (cg-RX-API-DMAC7.html)
CY (4) CY1105779T1 (cg-RX-API-DMAC7.html)
DE (4) DE122007000034I1 (cg-RX-API-DMAC7.html)
DK (1) DK1165126T3 (cg-RX-API-DMAC7.html)
ES (1) ES2270822T3 (cg-RX-API-DMAC7.html)
FR (1) FR07C0026I2 (cg-RX-API-DMAC7.html)
LT (1) LTC1165126I2 (cg-RX-API-DMAC7.html)
LU (3) LU91326I2 (cg-RX-API-DMAC7.html)
NL (3) NL300268I1 (cg-RX-API-DMAC7.html)
PT (1) PT1165126E (cg-RX-API-DMAC7.html)
SI (1) SI1165126T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000057906A1 (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962777B1 (en) * 1997-09-05 2005-11-08 Medimmune, Inc. In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
US7351533B2 (en) 1997-09-05 2008-04-01 Medimmune, Inc. In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
EP1250593B1 (en) * 1999-12-09 2009-03-25 Medimmune, Inc. IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPs)
EP1409013B1 (en) * 2001-07-26 2009-11-18 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising aluminium adjuvants and histidine
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
DE10137102A1 (de) * 2001-07-30 2003-02-27 Deutsches Krebsforsch Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
WO2003068933A2 (en) * 2002-02-14 2003-08-21 Novavax, Inc. Optimization of gene sequences of virus-like particles for expression in insect cells
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
DE10237639A1 (de) * 2002-08-13 2004-02-26 Martin-Luther-Universität Halle-Wittenberg Verfahren zur Herstellung von virusanalogen Partikeln durch in vitro-Assemblierung von Kapsomeren oder von Kapsomeren, an die biologisch aktive Makromoleküle gebunden sind, bei gleichzeitiger Verpackung der Makromoleküle
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
ATE352316T1 (de) 2002-11-01 2007-02-15 Glaxosmithkline Biolog Sa Immunogene zusammensetzung
US7858098B2 (en) * 2002-12-20 2010-12-28 Glaxosmithkline Biologicals, S.A. Vaccine
AU2003293942B2 (en) 2002-12-20 2009-12-10 Glaxosmithkline Biologicals Sa HPV-16 and -18 L1 VLP vaccine
WO2006004173A1 (ja) * 2004-07-01 2006-01-12 The Circle For The Promotion Of Science And Engineering 生理的条件下でのウイルス粒子様構造体及びその形成方法
PE20060958A1 (es) * 2005-01-25 2006-10-27 Wyeth Res Ireland Ltd Protectores contra el esfuerzo cortante en la microfiltracion de la cosecha
AU2006270225A1 (en) * 2005-07-14 2007-01-25 Mayo Foundation For Medical Education And Research Paramyxoviridae virus preparations
WO2007020871A1 (ja) * 2005-08-12 2007-02-22 Astellas Pharma Inc. デプシペプチド含有注射液
WO2007027076A1 (es) * 2005-09-01 2007-03-08 Nuno Ayala Jose Luis Formula estabilizadora de vacunas con antígenos vivos para su uso en sistemas de vacunación masiva
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
AU2007249242B2 (en) * 2006-05-11 2014-02-27 Arbor Vita Corporation Method of protein extraction from cells
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
JP5313231B2 (ja) * 2008-03-31 2013-10-09 森永乳業株式会社 耐熱性を付与する薬剤及び組成物
US10190152B2 (en) * 2009-09-03 2019-01-29 Becton, Dickinson And Company Methods and compositions for direct chemical lysis
SI3246044T2 (sl) 2010-08-23 2024-06-28 Wyeth Llc Stabilne formulacije antigenov neisseria meningitidis RLP2086
PE20140173A1 (es) 2010-09-10 2014-02-20 Wyeth Llc Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis
KR101716557B1 (ko) 2012-03-09 2017-03-14 화이자 인코포레이티드 수막염균 조성물 및 이의 사용 방법
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
JP2015514696A (ja) 2012-03-18 2015-05-21 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ヒト・パピローマウイルスに対するワクチン接種方法
KR101559622B1 (ko) 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
JP6446377B2 (ja) 2013-03-08 2018-12-26 ファイザー・インク 免疫原性融合ポリペプチド
MX369534B (es) 2013-09-08 2019-11-11 Pfizer Composiciones de neisseria meningitidis y sus metodos.
KR20190049940A (ko) 2015-02-19 2019-05-09 화이자 인코포레이티드 나이세리아 메닌지티디스 조성물 및 그의 방법
BR112019014397A2 (pt) 2017-01-31 2020-02-11 Pfizer Inc. Composições de neisseria meningitidis e métodos das mesmas
US20200010850A1 (en) 2017-02-17 2020-01-09 The USA, as represeented by the Secretary, Dept. of Health and Human Services Efficient cell free production of papillomavirus gene transfer vectors
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
MX2022003682A (es) 2019-09-27 2022-04-25 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.
CN110987571A (zh) * 2019-12-31 2020-04-10 广州金域医学检验中心有限公司 一种单克隆多聚体m蛋白解聚方法
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0971696B1 (en) * 1997-02-06 2010-06-09 Merck Sharp & Dohme Corp. Thimerosal-free preservatives for vaccines
KR20010006169A (ko) 1997-04-08 2001-01-26 폴락 돈나 엘. 안정화된 사람 파필로마바이러스 제형물
EP1000157A1 (en) 1997-07-03 2000-05-17 University Technology Corporation Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy

Also Published As

Publication number Publication date
CY2007010I2 (el) 2009-11-04
ES2270822T3 (es) 2007-04-16
AR023166A1 (es) 2002-09-04
LU91326I9 (cg-RX-API-DMAC7.html) 2018-12-31
SI1165126T1 (sl) 2006-12-31
DE122007000033I1 (de) 2007-08-09
LU91328I9 (cg-RX-API-DMAC7.html) 2019-03-01
AU778937B2 (en) 2004-12-23
CY2007008I1 (el) 2009-11-04
LU91328I2 (fr) 2007-05-14
DK1165126T3 (da) 2007-01-08
JP4594534B2 (ja) 2010-12-08
CY2007010I1 (el) 2009-11-04
CA2368391C (en) 2011-06-07
KR20020013516A (ko) 2002-02-20
DE122007000034I1 (de) 2007-08-09
DE122007000032I1 (de) 2007-08-09
DE60030698T2 (de) 2007-07-19
DE60030698D1 (de) 2006-10-26
CY1105779T1 (el) 2010-07-28
NL300269I2 (nl) 2008-07-01
LU91327I9 (cg-RX-API-DMAC7.html) 2019-03-01
CY2007009I2 (el) 2010-07-28
LU91326I2 (fr) 2007-05-14
LTPA2007002I1 (lt) 2020-03-25
ATE339222T1 (de) 2006-10-15
NL300269I1 (nl) 2007-05-01
EP1165126B1 (en) 2006-09-13
NL300268I1 (nl) 2007-05-01
JP2002540167A (ja) 2002-11-26
CY2007009I1 (el) 2010-07-28
LU91327I2 (fr) 2007-05-14
US6245568B1 (en) 2001-06-12
CY2007008I2 (el) 2009-11-04
EP1165126A1 (en) 2002-01-02
NL300270I1 (nl) 2007-05-01
AU3909300A (en) 2000-10-16
US20010021385A1 (en) 2001-09-13
FR07C0026I1 (cg-RX-API-DMAC7.html) 2007-04-27
LTC1165126I2 (lt) 2020-04-27
CA2368391A1 (en) 2000-10-05
PT1165126E (pt) 2006-12-29
WO2000057906A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
FR07C0026I2 (fr) Procede de preparation d' un vaccin contre le papillomavirus aux particules viro-induites desassemblees et reassemblees
AP2002002397A0 (en) Respiratory syncytial virus replication inhibitors
IL147327A0 (en) Respiratory syncytial virus replication inhibitors
EP1179586A4 (en) SIMPLE CULTURE MEDIUM AND PREPARATION METHOD THEREOF
IL147328A0 (en) Respiratory syncytial virus replication inhibitors
AU2001272249A1 (en) Method and apparatus for multiple patient parameter variability analysis and display
AU2001236042A1 (en) Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
EP1261359A4 (en) IMPROVED COMPOSITION WITH ANTIALLERAL PROPERTIES AND METHOD FOR THE MANUFACTURE THEREOF
AU2001226029A1 (en) Pharmaceutical formulation and method for pulmonary and oral delivery
PL354322A1 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
HUP0104687A3 (en) Methods for preparing coated drug particles and pharmaceutical formulations thereof
AU2701801A (en) Method and system for measuring heart rate variability
AU4316299A (en) Oral immunization with papillomavirus virus-like particles
AU3393600A (en) Method for safely and effectively administering a drug by inhalation
AU2001269640A1 (en) Vaccine against the influenza virus and method for producing said virus vaccine
AU6964001A (en) Vaccine against the influenza virus and method for producing said virus vaccine
AU2992901A (en) Method for preparing and administering medicinal plant material
AU2002223013A1 (en) Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU2273301A (en) Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
IL172663A0 (en) A process for the preparation of ??-(phenoxy)phenylacetic acid derivatives
AU2001285817A1 (en) Koji molds and use thereof for preparing cholesterol-lowering products
AU8395901A (en) Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
AU2001282071A1 (en) Multiparticulate pharmaceutical dosage form and a method for producing the same
AU2002213755A1 (en) A vaccine for acids and its preparation and use